Clinical Trial Update: Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II) [NA]

View source ↗

Summary

The trial update reports cerebrovascular and cognitive improvements associated with resveratrol (resVida) and Fruitflow-II (CCIRF-II) in memory impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Memory Impairment

Drugs mentioned

• Fruitflow-II (Fruitflow II)
• resVida

Snippet

Sponsor: Neurolgy Institute for Brain Health and Fitness | Conditions: Memory Impairment | NA | Status: UNKNOWN